Abstract
Radiotherapy is an important part of state-of-the art multidisciplinary treatment for breast cancer, typically in the postoperative setting. Increased locoregional tumor control has been shown to improve long-term survival. Additional systemic therapy is essential to eradicate distant disease before overt metastases develop. Treatment planning has evolved from simulator-based 2-dimensional to 3-dimensional and now also 4-dimensional techniques, which account for breathing-related changes. Eventually, better sparing of organs at risk such as lungs and heart could be accomplished. International efforts towards harmonization of target volume delineation have been successful. These aspects as well as emerging developments including partial breast irradiation are discussed in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alço G, Iğdem S, Ercan T et al (2010) Coverage of axillary lymph nodes with high tangential fields in breast radiotherapy. Br J Radiol 83:1072–1076
Andratschke N, Maurer J, Molls M et al (2011) Late radiation-induced heart disease after radiotherapy. Clinical importance, radiobiological mechanisms and strategies of prevention. Radiother Oncol 100:160–166
Antonini N, Jones H, Horiot JC et al (2007) Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881–10882. Radiother Oncol 82:265–271
Arthur DW, Winter K, Kuske RR et al (2008) A phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95–17. Int J Radiat Oncol Biol Phys 72:467–473
Atean I, Pointreau Y, Ouldamer L et al (2013) A simplified CT-based definition of the supraclavicular and infraclavicular nodal volumes in breast cancer. Cancer Radiother 17:39–43
Bantema-Joppe EJ, Schilstra C, de Bock GH et al (2012) Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months’ follow-up. Int J Radiat Oncol Biol Phys 83:e471–e477
Barnett GC, Wilkinson JS, Moody AM et al (2012) Randomized controlled trial of forward-planned intensity modulated radiotherapy for early breast cancer: interim results at 2 years. Int J Radiat Oncol Biol Phys 82:715–723
Bartelink H, Horiot J-C, Poortmans PM et al (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881–10882 trial. J Clin Oncol 25:3259–3265
Belkacémi Y, Fourquet A, Cutuli B et al (2011) Radiotherapy for invasive breast cancer: guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence. Crit Rev Oncol Hematol 79:91–102
Bentzen SM, Agrawal RK, Aird EGA et al (2008a) The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 9:331–341
Bentzen SM, Agrawal RK, Aird EGA et al (2008b) The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 371:1098–1107
Biganzoli L, Wildiers H, Oakman C et al (2012) Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 13:e148–e160
Brooks JP, Danforth DN, Albert P et al (2005) Early ipsilateral breast tumor recurrences after breast conservation affect survival: an analysis of the National Cancer Institute randomized trial. Int J Radiat Oncol Biol Phys 62:785–789
Buchholz T, Haffty B (2008) Breast cancer: locally advanced and recurrent disease, postmastectomy radiation, and systemic therapies. In: Perez and Brady’s principles and practice of radiation oncology. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia
Budach W, Kammers K, Boelke E et al (2013) Adjuvant radio-therapy of regional lymph nodes in breast cancer – a meta-analysis of randomized trials. Radiat Oncol 8:267
Darby S, McGale P, Correa C et al.; Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707–1716
Dijkema IM, Hofman P, Raaijmakers CPJ et al (2004) Loco-regional conformal radiotherapy of the breast: delineation of the regional lymph node clinical target volumes in treatment position. Radiother Oncol 71:287–295
Dodwell D, Dyker K, Brown J et al (2005) A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer. Clin Oncol 17:618–622
Donovan E, James H, Bonora M et al (2012) Second cancer incidence risk estimates using BEIR VII models for standard and complex external beam radiotherapy for early breast cancer. Med Phys 39:5814
EBCTCG Early Breast Cancer Trialists’ Collaborative Group (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383:2127–2135
Fastner G, Sedlmayer F, Merz F et al (2013) IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis. Radiother Oncol 108:279–286
Feng M, Moran JM, Koelling T et al (2011) Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys 79:10–18
Freedman GM, Anderson PR, Hanlon AL et al (2005) Pattern of local recurrence after conservative surgery and whole-breast irradiation. Int J Radiat Oncol Biol Phys 61:1328–1336
Galecki J, Hicer-Grzenkowicz J, Grudzien-Kowalska M et al (2006) Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer – a review. Acta Oncol 45:280–284
Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575
Gujral DM, Sumo G, Owen JR et al (2011) Ipsilateral breast tumor relapse: local recurrence versus new primary tumor and the effect of whole-breast radiotherapy on the rate of new primaries. Int J Radiat Oncol Biol Phys 79:19–25
Haffty BG, Hunt KK, Harris JR et al (2011) Positive sentinel nodes without axillary dissection: implications for the radiation oncologist. J Clin Oncol 29:4479–4481
Hall EJ, Wuu C-S (2003) Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56:83–88
Harris EE, Correa C, Hwang W-T et al (2006) Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol 24:4100–4106
Haviland JS, Owen JR, Dewar JA et al (2013) The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 14:1086–1094
Hellman S (1997) Stopping metastases at their source. N Engl J Med 337:996–997
Hennequin C, Bossard N, Servagi-Vernat S et al (2013) Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy. Int J Radiat Oncol Biol Phys 86:860–866
Hopwood P, Haviland JS, Sumo G et al (2010) Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. Lancet Oncol 11:231–240
Hurkmans CW, Meijer GJ, van Vliet-Vroegindeweij C et al (2006) High-dose simultaneously integrated breast boost using intensity-modulated radiotherapy and inverse optimization. Int J Radiat Oncol Biol Phys 66:923–930
ICRU (1993) ICRU report 50; prescribing, recording and reporting photon beam therapy
ICRU (1999) ICRU Report 62. Prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50)
Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms, Langversion 3.0, Aktualisierung 2012, AWMF-Register-Nummer: 032–045OL 2012
Jalali R, Singh S, Budrukkar A (2007) Techniques of tumour bed boost irradiation in breast conserving therapy: current evidence and suggested guidelines. Acta Oncol 46:879–892
James ML, Lehman M, Hider PN et al (2010) Fraction size in radiation treatment for breast conservation in early breast cancer. Cochrane Database Syst Rev:CD003860
Kirby AM, Evans PM, Helyer SJ et al (2011) A randomised trial of Supine versus Prone breast radiotherapy (SuPr study): comparing set-up errors and respiratory motion. Radiother Oncol 100:221–226
Kirova YM, Castro Pena P, Dendale R et al (2010) Simplified rules for everyday delineation of lymph node areas for breast cancer radiotherapy. Br J Radiol 83:683–686
Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11:927–933
Leonard KL, Solomon D, Hepel JT et al (2012) Axillary lymph node dose with tangential whole breast radiation in the prone versus supine position: a dosimetric study. Radiat Oncol 7:72
Lewin AA, Derhagopian R, Saigal K et al (2012) Accelerated partial breast irradiation is safe and effective using intensity-modulated radiation therapy in selected early-stage breast cancer. Int J Radiat Oncol Biol Phys 82:2104–2110
Lin A, Moran JM, Marsh RB et al (2008) Evaluation of multiple breathing states using a Multiple Instance Geometry Approximation (MIGA) in inverse-planned optimization for locoregional breast treatment. Int J Radiat Oncol Biol Phys 72:610–616
Lohr F, El-Haddad M, Dobler B et al (2009) Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality. Int J Radiat Oncol Biol Phys 74:73–80
Lupe K, Truong PT, Alexander C et al (2011) Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection. Int J Radiat Oncol Biol Phys 81:e681–e688
Matzinger O, Heimsoth I, Poortmans P et al (2010) Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925). Acta Oncol 49:24–34
Moser EC, Vrieling C (2012) Accelerated partial breast irradiation: The need for well-defined patient selection criteria, improved volume definitions, close follow-up and discussion of salvage treatment. Breast 21:707–715
Murthy V, Ballehaninna UK, Chamberlain RS (2012) Unanswered questions about the role of axillary dissection in women with invasive breast cancer and sentinel node metastasis. Clin Breast Cancer 12:305–307
Nairz O, Deutschmann H, Kopp M et al (2006) A dosimetric comparison of IORT techniques in limited-stage breast cancer. Strahlenther Onkol 182:342–348
NCCN (2014) Breast cancer version 3.2014. J Natl Compr Canc Netw 12:542–590
NICE (2009) Early and locally advanced breast cancer: diagnosis and treatment. National Institute for Clinical Excellence (NICE), London
Nielsen MH, Berg M, Pedersen AN et al (2013) Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncol 52:703–710
New Zealand Guidelines Group (NZGG) (2009) Management of early breast cancer – evidence-based best practice guidelines. New Zealand Guidelines Group, Wellington
Offersen BV, Boersma LJ, Kirkove C et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol. 2015;114(1):3–10
Ott OJ, Hildebrandt G, Pötter R et al (2007) Accelerated partial breast irradiation with multi-catheter brachytherapy: local control, side effects and cosmetic outcome for 274 patients. Results of the German–Austrian multi-centre trial. Radiother Oncol 82:281–286
Overgaard M, Nielsen HM, Overgaard J (2007) Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 82:247–253
Owen JR, Ashton A, Bliss JM et al (2006) Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 7:467–471
Pepels MJ, de Boer M, Bult P et al (2012) Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells. Ann Surg 255:116–121
Polgár C, Major T (2009) Current status and perspectives of brachytherapy for breast cancer. Int J Clin Oncol 14:7–24
Polgár C, Limbergen EV, Pötter R et al (2010) Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol 94:264–273
Polgár C, Fodor J, Major T et al (2013) Breast-conserving therapy with partial or whole breast irradiation: Ten-year results of the Budapest randomized trial. Radiother Oncol 108(2):197–202
Poortmans PM, Collette L, Horiot JC et al (2009) Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. Radiother Oncol 90:80–85
Poortmans P, Kirkove C, Budach V et al (2013) Irradiation of the internal mammary and medial supraclavicular lymph nodes in stage I to III breast cancer: 10 years results of the EORTC Radiation Oncology and Breast Cancer Groups phase III trial 22922/10925. EJC 47(Suppl 2): Abstract
Rabinovitch R, Ballonoff A, Newman F et al (2008) Evaluation of breast sentinel lymph node coverage by standard radiation therapy fields. Int J Radiat Oncol Biol Phys 70:1468–1471
Ragaz J, Olivotto IA, Spinelli JJ et al (2005) Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia Randomized Trial. J Natl Cancer Inst 97:116–126
Reznik J, Cicchetti MG, Degaspe B et al (2005) Analysis of axillary coverage during tangential radiation therapy to the breast. Int J Radiat Oncol Biol Phys 61:163–168
Ribeiro G, Magee B, Swindell R et al (1993) The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol 5:278–283
Romestaing P, Lehingue Y, Carrie C et al (1997) Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 15:963–968
RTOG. Breast cancer atlas for radiation therapy planning: consensus definitions. http://www.rtog.org/CoreLab/ContouringAtlases/BreastCancerAtlas.aspx. Accessed 30 Apr 2014
Rudat V, Alaradi AA, Mohamed A et al (2011) Tangential beam IMRT versus tangential beam 3D-CRT of the chest wall in postmastectomy breast cancer patients: a dosimetric comparison. Radiat Oncol 6:26
Rutgers EJ, Donker M, Straver ME et al (2013) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: final analysis of the EORTC AMAROS trial (10981/22023). J Clin Oncol 31:abstract LBA1001
Sautter-Bihl M-L, Sedlmayer F, Budach W et al (2010) Intraoperative radiotherapy as accelerated partial breast irradiation for early breast cancer: beware of one-stop shops? Strahlenther Onkol 186:651–657
Sautter-Bihl ML, Sedlmayer F, Budach W et al (2012) When are breast cancer patients old enough for the quitclaim of local control? Strahlenther Onkol 188:1069–1073
Sautter-Bihl M-L, Sedlmayer F, Budach W et al (2014) DEGRO practical guidelines: radiotherapy of breast cancer III—radiotherapy of the lymphatic pathways. Strahlenther Onkol 190:342–351
Schlembach PJ, Buchholz TA, Ross MI et al (2001) Relationship of sentinel and axillary level I–II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys 51:671–678
Sedlmayer F, Sautter-Bihl M-L, Budach W et al (2013a) DEGRO practical guidelines: radiotherapy of breast cancer I. Strahlenther Onkol 189:825–833
Sedlmayer F, Sautter-Bihl ML, Budach W et al (2013b) Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy? Strahlenther Onkol 189:193–196
Shah AP, Strauss JB, Kirk MC et al (2010) A dosimetric analysis comparing electron beam with the MammoSite brachytherapy applicator for intact breast boost. Phys Med 26:80–87
Shah C, Wilkinson JB, Baschnagel A et al (2012) Factors associated with the development of breast cancer-related lymphedema after whole-breast irradiation. Int J Radiat Oncol Biol Phys 83:1095–1100
Smith BD, Arthur DW, Buchholz TA et al (2009) Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74:987–1001
Smith BD, Bentzen SM, Correa CR et al (2011) Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline. Int J Radiat Oncol Biol Phys 81:59–68
Straver ME, Meijnen P, van Tienhoven G et al (2010) Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol 28:731–737
Swanson T, Grills IS, Ye H et al (2013) Six-year experience routinely using moderate deep inspiration breath-hold for the reduction of cardiac dose in left-sided breast irradiation for patients with early-stage or locally advanced breast cancer. Am J Clin Oncol 36:24–30
Théberge V, Whelan T, Shaitelman SF et al (2011) Altered fractionation: rationale and justification for whole and partial breast hypofractionated radiotherapy. Semin Radiat Oncol 21:55–65
Vaidya JS, Joseph DJ, Tobias JS et al (2010) Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 376:91–102
Vaidya JS, Baum M, Tobias JS et al (2011) Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery. Int J Radiat Oncol Biol Phys 81:1091–1097
Vaidya J, Wenz F, Bulsara M (2014) Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet 383:602
Valachis A, Mauri D, Polyzos NP et al (2010) Partial breast irradiation or whole breast radiotherapy for early breast cancer: a meta-analysis of randomized controlled trials. Breast J 16:245–251
van der Laan HP, Hurkmans CW, Kuten A et al (2010) Current technological clinical practice in breast radiotherapy; results of a survey in EORTC-Radiation Oncology Group affiliated institutions. Radiother Oncol 94:280–285
Van Parijs H, Miedema G, Vinh-Hung V et al (2012) Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial. Radiat Oncol 7:80
van Wely BJ, Teerenstra S, Schinagl DA et al (2011) Systematic review of the effect of external beam radiation therapy to the breast on axillary recurrence after negative sentinel lymph node biopsy. Br J Surg 98:326–333
Veronesi U, Orecchia R, Luini A et al (2010) Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat 124:141–151
Veronesi U, Orecchia R, Maisonneuve P et al (2013) Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol 14:1269–1277
Vicini F, Winter K, Wong J et al (2010) Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/II breast carcinoma. Int J Radiat Oncol Biol Phys 77:1120–1127
Weaver DL, Ashikaga T, Krag DN et al (2011) Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 364:412–421
Whelan TJ, Pignol J-P, Levine MN et al (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362:513–520
Whelan T, Olivotto I, Ackerman I et al (2011) NCIC-CTG MA. 20: an intergroup trial of regional nodal irradiation in early breast cancer. J Clin Oncol 29(Suppl):abstract LBA 1003
Zurl B, Stranzl H, Winkler P et al (2010) Quantitative assessment of irradiated lung volume and lung mass in breast cancer patients treated with tangential fields in combination with deep inspiration breath hold (DIBH). Strahlenther Onkol 186:157–162
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sautter-Bihl, ML., Melcher, U., Sedlmayer, F. (2015). Breast Cancer. In: Grosu, AL., Nieder, C. (eds) Target Volume Definition in Radiation Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45934-8_17
Download citation
DOI: https://doi.org/10.1007/978-3-662-45934-8_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45933-1
Online ISBN: 978-3-662-45934-8
eBook Packages: MedicineMedicine (R0)